BioSpace News Archive

enGene Inc., a biotechnology company developing non-viral gene therapies for local administration into mucosal tissues enabled by its proprietary DDX platform, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to enGene for EG-70,

Veracyte, Inc. (Nasdaq: VCYT), a global genomic diagnostics company, will host a Virtual Lung Cancer R&D Day for investors and analysts on December 16, 2020, from 10:00 a.m. to 12:00 p.m. EST. The event will feature Veracyte senior management who will provide an overview of the company’s vision for transforming patient care in lung cancer, as well as leading pulmonologists who will discuss the chall

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, today announced that it will be participating in the Benzinga Global Small Cap Conference being held virtually on December 8 and 9, 2020

IN8bio, Inc., a clinical-stage biotechnology company focused on developing innovative allogeneic, autologous and genetically modified gamma-delta T cell therapies for the treatment of cancers (“IN8bio” or the “Company”), today announced an upcoming presentation that provides an update of the ongoing Phase I clinical trial of their product candidate INB-100 at the 62nd American Society of Hematology Annual Meeting & Exposition

The Lupus Research Alliance is proud to announce the 2020 recipients of its Lupus Mechanisms and Targets Award (LMTA).

ERYTECH Pharma (Nasdaq & Euronext: ERYP),a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announcesa webcast scheduled for investors to discuss the results from the NOPHO sponsored Phase 2 trial of eryaspase in ALL patients.

CooperCompanies announced financial results for its fiscal fourth quarter and full year ended October 31, 2020.

Bringing the comfort of a personal movie theater into the MRI scanning procedure.

ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that Centre Hospitalier Universitaire;Angers, France (CHU Angers), a world-renowned healthcare institution, is partnering with ENDRA for a clinical study of ENDRA;s Thermo Acoustic Enhanced

BioLife Sciences Inc. (OTCPK: BLFE) is pleased to announce the appointment of new board members and officers, effective as of December 1st, 2020. BioLife Sciences welcomes distinguished new members, Dr. Nataliya Hearn and Mr. Brian Morales, to the company’s Board of Directors. Professor turned serial entrepreneur, Dr. Hearn brings a deep and diverse set of skills and experience to BioLife Sciences, focused on the imp